25 Aug Omixy: Diagnosis and Treatment with Genomics & Exponential Technology
Co-Founder & CEO: Lavinia Ionita
Omixy is reinventing the check-up with an integrative “omics” approach that brings the whole genome sequencing together with medical expertise. Metabolomics is an emerging field of “omics” science, the purpose of which is to develop a comprehensive analysis of the metabolome, that includes all of the small molecules produced in the cells of living organisms.
The majority of direct-to-consumer genetic tests use genotyping technologies, which means that they look only at specific regions of DNA, rather than sequencing the whole genome. Omixy looks at all of the information in your DNA, because that presents the whole picture. And even if today they can’t interpret every single piece of data that is encoded on your DNA, considering the exponential technological progress taking place in the field, Omixy will continually update your results based on cutting-edge genomic advances.
It all starts with a simple check you can order online with an option to go to a clinic or have a nurse visit you at home or your office.
Why we love Omixy: The company is gearing up for the exponential technologies to hit mainstream healthcare that will change the way disease is prevented, diagnosed and treated. We. cannot. wait.
Globally Spotted by: James O’Donnell